Nuclear Medicine Market By Type, Modality, Application and End User - Global Industry Analysis And Forecast To 2027
Published On : February 2019 Pages : 160 Category: Pharmaceuticals Report Code : HC022562
Nuclear Medicine Market By Type (Therapeutic and Diagnostic), Modality (Brachytherapy, SPECT, Beta-Emitters, PET and Alpha-Emitters), Application (Thyroid, Oncology, Neurology, Cardiology and Other Applications) and End User (Research Institutes and Hospitals & Diagnostic Centers) - Global Industry Analysis And Forecast To 2027
Industry Outlook
Nuclear Medicine are the medicines that use small amount of radioactive material known as radiotracers, that are normally administered through injection into bloodstream, swallowing or inhaling. These medicines are applicable for both diagnosis and treatment of particular disease. These radiotracers g through the affected area & give out energy in gamma rays form which are then traced using special cameras to create images of body inside. The imaging results using this medicine are way better than that done using traditional imaging. The use of theses medicines is growing due to factor like; increasing number of cases related to cardiovascular disorders & cancer, rising need for accurate & initial diagnosis methods, increasing demand for better treatment of various diseases, etc. Therefore, the Nuclear Medicine Market is anticipated to expand and has tremendous scope during the forecast period. The global Nuclear Medicine Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global Nuclear Medicine Market is based on segment, by Type the market is segmented into Therapeutic and Diagnostic, by Modality the market is segmented into Brachytherapy, SPECT, Beta-Emitters, PET and Alpha-Emitters, by Application the market is segmented into Thyroid, Oncology, Neurology, Cardiology and Other Applications, and by End User the market is segmented into Research Institutes and Hospitals & Diagnostic Centers.
- Nuclear Medicine Market, By Type
- Therapeutic
- Diagnostic
- Nuclear Medicine Market, By Modality
- Brachytherapy
- SPECT
- Beta-Emitters
- PET
- Alpha-Emitters
- Nuclear Medicine Market, By Application
- Thyroid
- Oncology
- Neurology
- Cardiology
- Other Applications
- Nuclear Medicine Market, By End User
- Research Institutes
- Hospitals & Diagnostic Centers
Regional Insights
On a global front, the Nuclear Medicine Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is dominating the global market due to development in the healthcare sector in this region and rising number of cases related to cancer & various cardiovascular problems.
Nuclear Medicine Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are Bracco Imaging S.p.A, Mallinckrodt plc., Nordion Inc., GE Healthcare, Jubilant Life Sciences, Medtronic Inc., Eckert & Ziegler Group, Bayer AG, IBA Group, Cardinal Health Inc. and Lantheus Medical Imaging Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Bracco Imaging S.p.A
- Mallinckrodt plc.
- Nordion Inc.
- GE Healthcare
- Jubilant Life Sciences
- Medtronic Inc.
- Eckert & Ziegler Group
- Bayer AG
- IBA Group
- Cardinal Health Inc.
- Lantheus Medical Imaging Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Nuclear Medicine Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Therapeutic
o Diagnostic
o Nuclear Medicine Market, By Modality, Estimates and Forecast, 2017-2027 ($Million)
o Brachytherapy
o SPECT
o Beta-Emitters
o PET
o Alpha-Emitters
o Nuclear Medicine Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Thyroid
o Oncology
o Neurology
o Cardiology
o Other Applications
o Nuclear Medicine Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Research Institutes
o Hospitals & Diagnostic Centers
o Nuclear Medicine Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Nuclear Medicine Market, By Country
o U.S. Nuclear Medicine Market
o Canada Nuclear Medicine Market
o Mexico Nuclear Medicine Market
o Europe
§ Europe Nuclear Medicine Market, By Country
o Germany Nuclear Medicine Market
o UK Nuclear Medicine Market
o France Nuclear Medicine Market
o Russia Nuclear Medicine Market
o Italy Nuclear Medicine Market
o Rest of Europe Nuclear Medicine Market
o Asia-Pacific
§ Asia-Pacific Nuclear Medicine Market, By Country
o China Nuclear Medicine Market
o Japan Nuclear Medicine Market
o South Korea Nuclear Medicine Market
o India Nuclear Medicine Market
o Southeast Asia Nuclear Medicine Market
o Rest of Asia-Pacific Nuclear Medicine Market
o South America
§ South America Nuclear Medicine Market, By Country
o Brazil Nuclear Medicine Market
o Argentina Nuclear Medicine Market
o Columbia Nuclear Medicine Market
o Rest of South America Nuclear Medicine Market
o Middle East and Africa
§ Middle East and Africa Nuclear Medicine Market, By Country
o Saudi Arabia Nuclear Medicine Market
o UAE Nuclear Medicine Market
o Egypt Nuclear Medicine Market
o Nigeria Nuclear Medicine Market
o South Africa Nuclear Medicine Market
o Rest of MEA Nuclear Medicine Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Nuclear Medicine Market, By Type
5.1. Introduction
5.2. Global Nuclear Medicine Revenue and Market Share by Type (2017-2027)
5.2.1. Global Nuclear Medicine Revenue and Revenue Share by Type (2017-2027)
5.3. Therapeutic
5.3.1. Global Therapeutic Revenue and Growth Rate (2017-2027)
5.4. Diagnostic
5.4.1. Global Diagnostic Revenue and Growth Rate (2017-2027)
6. Nuclear Medicine Market, By Modality
6.1. Introduction
6.2. Global Nuclear Medicine Revenue and Market Share by Modality (2017-2027)
6.2.1. Global Nuclear Medicine Revenue and Revenue Share by Modality (2017-2027)
6.3. Brachytherapy
6.3.1. Global Brachytherapy Revenue and Growth Rate (2017-2027)
6.4. SPECT
6.4.1. Global SPECT Revenue and Growth Rate (2017-2027)
6.5. Beta-Emitters
6.5.1. Global Beta-Emitters Revenue and Growth Rate (2017-2027)
6.6. PET
6.6.1. Global PET Revenue and Growth Rate (2017-2027)
6.7. Alpha-Emitters
6.7.1. Global Alpha-Emitters Revenue and Growth Rate (2017-2027)
7. Nuclear Medicine Market, By Application
7.1. Introduction
7.2. Global Nuclear Medicine Revenue and Market Share by Application (2017-2027)
7.2.1. Global Nuclear Medicine Revenue and Revenue Share by Application (2017-2027)
7.3. Thyroid
7.3.1. Global Thyroid Revenue and Growth Rate (2017-2027)
7.4. Oncology
7.4.1. Global Oncology Revenue and Growth Rate (2017-2027)
7.5. Neurology
7.5.1. Global Neurology Revenue and Growth Rate (2017-2027)
7.6. Cardiology
7.6.1. Global Cardiology Revenue and Growth Rate (2017-2027)
7.7. Other Applications
7.7.1. Global Other Applications Revenue and Growth Rate (2017-2027)
8. Nuclear Medicine Market, By End User
8.1. Introduction
8.2. Global Nuclear Medicine Revenue and Market Share by End User (2017-2027)
8.2.1. Global Nuclear Medicine Revenue and Revenue Share by End User (2017-2027)
8.3. Research Institutes
8.3.1. Global Research Institutes Revenue and Growth Rate (2017-2027)
8.4. Hospitals & Diagnostic Centers
8.4.1. Global Hospitals & Diagnostic Centers Revenue and Growth Rate (2017-2027)
9. Nuclear Medicine Market, By Region
9.1. Introduction
9.2. Global Nuclear Medicine Revenue and Market Share by Regions
9.2.1. Global Nuclear Medicine Revenue by Regions (2017-2027)
9.3. North America Nuclear Medicine by Countries
9.3.1. North America Nuclear Medicine Revenue and Growth Rate (2017-2027)
9.3.2. North America Nuclear Medicine Revenue (Million USD) by Countries (2017-2027)
9.3.3. United States
9.3.3.1. United States Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.3.4. Canada
9.3.4.1. Canada Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.3.5. Mexico
9.3.5.1. Mexico Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.4. Europe Nuclear Medicine by Countries
9.4.1. Europe Nuclear Medicine Revenue and Growth Rate (2017-2027)
9.4.2. Europe Nuclear Medicine Revenue (Million USD) by Countries (2017-2027)
9.4.3. Germany
9.4.3.1. Germany Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.4. France
9.4.4.1. France Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.5. UK
9.4.5.1. UK Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.6. Russia
9.4.6.1. Russia Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.7. Italy
9.4.7.1. Italy Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.8. Rest of Europe
9.4.8.1. Rest of Europe Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.5. Asia-Pacific Nuclear Medicine by Countries
9.5.1. Asia-Pacific Nuclear Medicine Revenue and Growth Rate (2017-2027)
9.5.2. Asia-Pacific Nuclear Medicine Revenue (Million USD) by Countries (2017-2027)
9.5.3. China
9.5.3.1. China Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.4. Japan
9.5.4.1. Japan Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.5. Korea
9.5.5.1. Korea Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.6. India
9.5.6.1. India Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.7. Southeast Asia
9.5.7.1. Southeast Asia Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.8. Rest of Asia-Pacific
9.5.8.1. Rest of Asia-Pacific Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.6. South America Nuclear Medicine by Countries
9.6.1. South America Nuclear Medicine Revenue and Growth Rate (2017-2027)
9.6.2. South America Nuclear Medicine Revenue (Million USD) by Countries (2017-2027)
9.6.3. Brazil
9.6.3.1. Brazil Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.6.4. Argentina
9.6.4.1. Argentina Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.6.5. Columbia
9.6.5.1. Columbia Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.6.6. Rest of South America
9.6.6.1. Rest of South America Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.7. Middle East and Africa Nuclear Medicine by Countries
9.7.1. Middle East and Africa Nuclear Medicine Revenue and Growth Rate (2017-2027)
9.7.2. Middle East and Africa Nuclear Medicine Revenue (Million USD) by Countries (2017-2027)
9.7.3. Saudi Arabia
9.7.3.1. Saudi Arabia Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.4. United Arab Emirates
9.7.4.1. United Arab Emirates Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.5. Egypt
9.7.5.1. Egypt Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.6. Nigeria
9.7.6.1. Nigeria Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.7. South Africa
9.7.7.1. South Africa Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.8. Turkey
9.7.8.1. Turkey Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.9. Rest of Middle East and Africa
9.7.9.1. Rest of Middle East and Africa Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
10. Company Profiles
10.1. Bracco Imaging S.p.A
10.1.1. Business Overview
10.1.2. Service Portfolio
10.1.3. Strategic Developments
10.1.4. Revenue and Market Share
10.2. Mallinckrodt plc.
10.2.1. Business Overview
10.2.2. Service Portfolio
10.2.3. Strategic Developments
10.2.4. Revenue and Market Share
10.3. Nordion Inc.
10.3.1. Business Overview
10.3.2. Service Portfolio
10.3.3. Strategic Developments
10.3.4. Revenue and Market Share
10.4. GE Healthcare
10.4.1. Business Overview
10.4.2. Service Portfolio
10.4.3. Strategic Developments
10.4.4. Revenue and Market Share
10.5. Jubilant Life Sciences
10.5.1. Business Overview
10.5.2. Service Portfolio
10.5.3. Strategic Developments
10.5.4. Revenue and Market Share
10.6. Medtronic Inc.
10.6.1. Business Overview
10.6.2. Service Portfolio
10.6.3. Strategic Developments
10.6.4. Revenue and Market Share
10.7. Eckert & Ziegler Group
10.7.1. Business Overview
10.7.2. Service Portfolio
10.7.3. Strategic Developments
10.7.4. Revenue and Market Share
10.8. Bayer AG
10.8.1. Business Overview
10.8.2. Service Portfolio
10.8.3. Strategic Developments
10.8.4. Revenue and Market Share
10.9. IBA Group
10.9.1. Business Overview
10.9.2. Service Portfolio
10.9.3. Strategic Developments
10.9.4. Revenue and Market Share
10.10. Cardinal Health Inc.
10.10.1. Business Overview
10.10.2. Service Portfolio
10.10.3. Strategic Developments
10.10.4. Revenue and Market Share
10.11. Lantheus Medical Imaging Inc.
10.11.1. Business Overview
10.11.2. Service Portfolio
10.11.3. Strategic Developments
10.11.4. Revenue and Market Share
11. Global Nuclear Medicine Market Competition, by Manufacturer
11.1. Global Nuclear Medicine Revenue and Market Share by Manufacturer (2017-2017)
11.2. Global Nuclear Medicine Price By Region (2017-2017)
11.3. Top 5 Nuclear Medicine Manufacturer Market Share
11.4. Market Competition Trend
12. Nuclear Medicine Market Forecast (2017-2027)
12.1. Global Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2027)
12.2. Nuclear Medicine Market Forecast by Regions (2017-2027)
12.2.1. North America Nuclear Medicine Market Forecast (2017-2027)
12.2.1.1. United States Nuclear Medicine Market Forecast (2017-2027)
12.2.1.2. Canada Nuclear Medicine Market Forecast (2017-2027)
12.2.1.3. Mexico Nuclear Medicine Market Forecast (2017-2027)
12.2.2. Europe Nuclear Medicine Market Forecast (2017-2027)
12.2.2.1. Germany Nuclear Medicine Market Forecast (2017-2027)
12.2.2.2. France Nuclear Medicine Market Forecast (2017-2027)
12.2.2.3. UK Nuclear Medicine Market Forecast (2017-2027)
12.2.2.4. Russia Nuclear Medicine Market Forecast (2017-2027)
12.2.2.5. Italy Nuclear Medicine Market Forecast (2017-2027)
12.2.2.6. Rest of Europe Nuclear Medicine Market Forecast (2017-2027)
12.2.3. Asia-Pacific Nuclear Medicine Market Forecast (2017-2027)
12.2.3.1. China Nuclear Medicine Market Forecast (2017-2027)
12.2.3.2. Japan Nuclear Medicine Market Forecast (2017-2027)
12.2.3.3. Korea Nuclear Medicine Market Forecast (2017-2027)
12.2.3.4. India Nuclear Medicine Market Forecast (2017-2027)
12.2.3.5. Southeast Asia Nuclear Medicine Market Forecast (2017-2027)
12.2.3.6. Rest of Asia-Pacific Nuclear Medicine Market Forecast (2017-2027)
12.2.4. South America Nuclear Medicine Market Forecast (2017-2027)
12.2.4.1. Brazil Nuclear Medicine Market Forecast (2017-2027)
12.2.4.2. Argentina Nuclear Medicine Market Forecast (2017-2027)
12.2.4.3. Columbia Nuclear Medicine Market Forecast (2017-2027)
12.2.4.4. Rest of South America Nuclear Medicine Market Forecast (2017-2027)
12.2.5. Middle East and Africa Nuclear Medicine Market Forecast (2017-2027)
12.2.5.1. Saudi Arabia Nuclear Medicine Market Forecast (2017-2027)
12.2.5.2. United Arab Emirates Nuclear Medicine Market Forecast (2017-2027)
12.2.5.3. Egypt Nuclear Medicine Market Forecast (2017-2027)
12.2.5.4. Nigeria Nuclear Medicine Market Forecast (2017-2027)
12.2.5.5. South Africa Nuclear Medicine Market Forecast (2017-2027)
12.2.5.6. Turkey Nuclear Medicine Market Forecast (2017-2027)
12.2.5.7. Rest of Middle East and Africa Nuclear Medicine Market Forecast (2017-2027)
12.3. Nuclear Medicine Market Forecast by Type (2017-2027)
12.3.1. Nuclear Medicine Forecast by Type (2017-2027)
12.3.2. Nuclear Medicine Market Share Forecast by Type (2017-2027)
12.4. Nuclear Medicine Market Forecast by Modality (2017-2027)
12.4.1. Nuclear Medicine Forecast by Modality (2017-2027)
12.4.2. Nuclear Medicine Market Share Forecast by Modality (2017-2027)
12.5. Nuclear Medicine Market Forecast by Application (2017-2027)
12.5.1. Nuclear Medicine Forecast by Application (2017-2027)
12.5.2. Nuclear Medicine Market Share Forecast by Application (2017-2027)
12.6. Nuclear Medicine Market Forecast by End User (2017-2027)
12.6.1. Nuclear Medicine Forecast by End User (2017-2027)
12.6.2. Nuclear Medicine Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Nuclear Medicine Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Nuclear Medicine Revenue and Revenue Share by Type (2017-2018)
Figure Global Therapeutic Revenue and Growth Rate (2017-2018)
Figure Global Diagnostic Revenue and Growth Rate (2017-2018)
Table Global Nuclear Medicine Revenue and Revenue Share by Modality (2017-2018)
Figure Global Brachytherapy Revenue and Growth Rate (2017-2018)
Figure Global SPECT Revenue and Growth Rate (2017-2018)
Figure Global Beta-Emitters Revenue and Growth Rate (2017-2018)
Figure Global PET Revenue and Growth Rate (2017-2018)
Figure Global Alpha-Emitters Revenue and Growth Rate (2017-2018)
Table Global Nuclear Medicine Revenue and Revenue Share by Application (2017-2018)
Figure Global Thyroid Revenue and Growth Rate (2017-2018)
Figure Global Oncology Revenue and Growth Rate (2017-2018)
Figure Global Neurology Revenue and Growth Rate (2017-2018)
Figure Global Cardiology Revenue and Growth Rate (2017-2018)
Figure Global Other Applications Revenue and Growth Rate (2017-2018)
Table Global Nuclear Medicine Revenue and Revenue Share by End User (2017-2018)
Figure Global Research Institutes Revenue and Growth Rate (2017-2018)
Figure Global Hospitals & Diagnostic Centers Revenue and Growth Rate (2017-2018)
Table Global Nuclear Medicine Revenue by Regions (2017-2018)
Figure North America Nuclear Medicine Growth Rate (2017-2018)
Figure North America Nuclear Medicine Revenue and Growth Rate (2017-2018)
Figure North America Nuclear Medicine by Countries (2017-2018)
Figure North America Nuclear Medicine Revenue (Million USD) by Countries (2017-2018)
Figure United States Nuclear Medicine Growth Rate (2017-2018)
Figure United States Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Nuclear Medicine Growth Rate (2017-2018)
Figure Canada Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Nuclear Medicine Growth Rate (2017-2018)
Figure Mexico Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Nuclear Medicine Growth Rate (2017-2018)
Figure Europe Nuclear Medicine Revenue and Growth Rate (2017-2018)
Figure Europe Nuclear Medicine by Countries (2017-2018)
Figure Europe Nuclear Medicine Revenue (Million USD) by Countries (2017-2018)
Figure Germany Nuclear Medicine Growth Rate (2017-2018)
Figure Germany Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Nuclear Medicine Growth Rate (2017-2018)
Figure France Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Nuclear Medicine Growth Rate (2017-2018)
Figure UK Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Nuclear Medicine Growth Rate (2017-2018)
Figure Russia Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Nuclear Medicine Growth Rate (2017-2018)
Figure Italy Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Nuclear Medicine Growth Rate (2017-2018)
Figure Rest of Europe Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Nuclear Medicine Growth Rate (2017-2018)
Figure Asia-Pacific Nuclear Medicine Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Nuclear Medicine by Countries (2017-2018)
Figure Asia-Pacific Nuclear Medicine Revenue (Million USD) by Countries (2017-2018)
Figure China Nuclear Medicine Growth Rate (2017-2018)
Figure China Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Nuclear Medicine Growth Rate (2017-2018)
Figure Japan Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Nuclear Medicine Growth Rate (2017-2018)
Figure Korea Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Nuclear Medicine Growth Rate (2017-2018)
Figure India Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Nuclear Medicine Growth Rate (2017-2018)
Figure Southeast Asia Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Nuclear Medicine Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Nuclear Medicine Growth Rate (2017-2018)
Figure South America Nuclear Medicine Revenue and Growth Rate (2017-2018)
Figure South America Nuclear Medicine by Countries (2017-2018)
Figure South America Nuclear Medicine Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Nuclear Medicine Growth Rate (2017-2018)
Figure Brazil Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Nuclear Medicine Growth Rate (2017-2018)
Figure Argentina Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Nuclear Medicine Growth Rate (2017-2018)
Figure Columbia Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Nuclear Medicine Growth Rate (2017-2018)
Figure Rest of South America Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Nuclear Medicine Growth Rate (2017-2018)
Figure Middle East and Africa Nuclear Medicine Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Nuclear Medicine by Countries (2017-2018)
Figure Middle East and Africa Nuclear Medicine Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Nuclear Medicine Growth Rate (2017-2018)
Figure Saudi Arabia Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Nuclear Medicine Growth Rate (2017-2018)
Figure United Arab Emirates Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Nuclear Medicine Growth Rate (2017-2018)
Figure Egypt Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Nuclear Medicine Growth Rate (2017-2018)
Figure Nigeria Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Nuclear Medicine Growth Rate (2017-2018)
Figure South Africa Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Nuclear Medicine Growth Rate (2017-2018)
Figure Turkey Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Nuclear Medicine Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Nuclear Medicine Revenue (Millions USD) and Growth Rate (2017-2018)
Table Bracco Imaging S.p.A Nuclear Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Mallinckrodt plc. Nuclear Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Nordion Inc. Nuclear Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GE Healthcare Nuclear Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Jubilant Life Sciences Nuclear Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Medtronic Inc. Nuclear Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Eckert & Ziegler Group Nuclear Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bayer AG Nuclear Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table IBA Group Nuclear Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cardinal Health Inc. Nuclear Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Lantheus Medical Imaging Inc. Nuclear Medicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Nuclear Medicine Market Share by Manufacturer
Figure Global Nuclear Medicine Revenue and Market Share by Manufacturer
Table Global Nuclear Medicine Price by Region (2017-2017)
Figure Top 5 Nuclear Medicine Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Nuclear Medicine Revenue (Millions USD) and Growth Rate (2018-2025)
Table Nuclear Medicine Market Forecast by Regions (2018-2025)
Figure North America Nuclear Medicine Market Forecast (2018-2025)
Figure United States Nuclear Medicine Market Forecast (2018-2025)
Figure Canada Nuclear Medicine Market Forecast (2018-2025)
Figure Mexico Nuclear Medicine Market Forecast (2018-2025)
Figure Europe Nuclear Medicine Market Forecast (2018-2025)
Figure Germany Nuclear Medicine Market Forecast (2018-2025)
Figure France Nuclear Medicine Market Forecast (2018-2025)
Figure UK Nuclear Medicine Market Forecast (2018-2025)
Figure Russia Nuclear Medicine Market Forecast (2018-2025)
Figure Italy Nuclear Medicine Market Forecast (2018-2025)
Figure Rest of Europe Nuclear Medicine Market Forecast (2018-2025)
Figure Asia-Pacific Nuclear Medicine Market Forecast (2018-2025)
Figure China Nuclear Medicine Market Forecast (2018-2025)
Figure Japan Nuclear Medicine Market Forecast (2018-2025)
Figure Korea Nuclear Medicine Market Forecast (2018-2025)
Figure India Nuclear Medicine Market Forecast (2018-2025)
Figure Southeast Asia Nuclear Medicine Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Nuclear Medicine Market Forecast (2018-2025)
Figure South America Nuclear Medicine Market Forecast (2018-2025)
Figure Brazil Nuclear Medicine Market Forecast (2018-2025)
Figure Argentina Nuclear Medicine Market Forecast (2018-2025)
Figure Columbia Nuclear Medicine Market Forecast (2018-2025)
Figure Rest of South America Nuclear Medicine Market Forecast (2018-2025)
Figure Middle East and Africa Nuclear Medicine Market Forecast (2018-2025)
Figure Saudi Arabia Nuclear Medicine Market Forecast (2018-2025)
Figure United Arab Emirates Nuclear Medicine Market Forecast (2018-2025)
Figure Egypt Nuclear Medicine Market Forecast (2018-2025)
Figure Nigeria Nuclear Medicine Market Forecast (2018-2025)
Figure South Africa Nuclear Medicine Market Forecast (2018-2025)
Figure Turkey Nuclear Medicine Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Nuclear Medicine Market Forecast (2018-2025)
Figure Global Nuclear Medicine Forecast by Type (2018-2025)
Figure Global Nuclear Medicine Market Share Forecast by Type (2018-2025)
Figure Global Nuclear Medicine Forecast by Type (2018-2025)
Figure Global Nuclear Medicine Forecast by Modality (2018-2025)
Figure Global Nuclear Medicine Market Share Forecast by Modality (2018-2025)
Figure Global Nuclear Medicine Forecast by Modality (2018-2025)
Figure Global Nuclear Medicine Forecast by Application (2018-2025)
Figure Global Nuclear Medicine Market Share Forecast by Application (2018-2025)
Figure Global Nuclear Medicine Forecast by Application (2018-2025)
Figure Global Nuclear Medicine Forecast by End User (2018-2025)
Figure Global Nuclear Medicine Market Share Forecast by End User (2018-2025)
Figure Global Nuclear Medicine Forecast by End User (2018-2025)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|